Forty51 Ventures

Venture capital firm focused on building biotech companies.

Profile being verified

Stage
Seed across recorded rounds
Ticket
Ticket sizes not disclosed; recorded rounds of USD 3.5 M to USD 5.1 M
Location
Not specified
Tracked rounds
2

What they look for

Founded FERROSA in Basel in 2026 and led its USD 3.5 M seed; co-founding investor in ALLEGRIA Therapeutics.

Recent investments

Recorded Swiss rounds: ALLEGRIA Therapeutics (seed, USD 5.1 M, December 2025), FERROSA (seed, USD 3.5 M, April 2026, lead).

Rounds tracked by FundSwiss